Zum Hauptinhalt springen

Buprenorphin

20. April 2025 | Buprenorphin

Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.

Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States. Ivasiy R…

18. April 2025 | Buprenorphin

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses.

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses. Leventelis C, Veskoukis AS, Rojas Gil AP, Papadopoulos P, Garderi M, Angeli A, Kampitsi A, Tsironi M. …

18. April 2025 | Buprenorphin

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder. Nosyk B, Min JE, Homayra F, et al. JAMA. 2024;332(21):1822–1831. doi:10.1001/jama.2024.16954 https://jamanetwork.com/journals/jama/fullarticl…

18. April 2025 | Buprenorphin

Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl.

Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl. Lee KW, Mead A, Ghauri I, Hollett B, Drolet M, Kozicky JM. Subst Abuse Rehabil. 2025 Mar 25;16:71-82. doi…

18. April 2025 | Buprenorphin

Trends in Extended-Release and Non-Extended-Release Buprenorphine Dispensing.

Trends in Extended-Release and Non-Extended-Release Buprenorphine Dispensing. Stopka TJ, Dalvi N, Young LD, Shrestha S, Valerio DD, Walley AY. JAMA Netw Open. 2025 Apr 1;8(4):e253158. doi: 10.1001/jamanetworkopen.2025.3158. PMID: 40184…

18. April 2025 | Buprenorphin

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder. Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthu…

15. März 2025 | Buprenorphin

The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021.

The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021. Stringfellow EJ, Dong H, Khatami SN, Lee H, J…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten